Literature DB >> 2658918

Oral prophylaxis with neomycin and erythromycin in colorectal surgery. More proof for efficacy than failure.

P A Kling1, S Dahlgren.   

Abstract

In an open, prospective, and randomized investigation on the prophylactic efficacy of peroral neomycin sulfate-erythromycin base vs intravenous ceftriaxone-metronidazole preparation in colorectal surgery, no significantly diverging results between regimens were recorded (1/27 [3.7%] and 2/27 [7.4%] wound infections, respectively). Commentary is made about the diverging results from earlier studies on antimicrobial prophylaxis and on the multifactorial causality of surgical infection. We believe that variables such as physical condition of the patients, virulence and local resistance patterns of bacteria, and technical skill of the surgeons are far more important in regard to the postoperative outcome concerning septic complications than is the choice of proper antibiotics. Thus, to determine the efficacy of antimicrobial prophylaxis, we call for larger investigations in the future, preferably double-blind, where it is possible to better control and diminish the influence of determinants other than the antibiotics being compared.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2658918     DOI: 10.1001/archsurg.1989.01410060075015

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  2 in total

Review 1.  The role of oral antibiotics prophylaxis in prevention of surgical site infection in colorectal surgery.

Authors:  Michalis Koullouros; Nadir Khan; Emad H Aly
Journal:  Int J Colorectal Dis       Date:  2016-10-24       Impact factor: 2.571

2.  Association of Mechanical Bowel Preparation and Oral Antibiotics Before Elective Colorectal Surgery With Surgical Site Infection: A Network Meta-analysis.

Authors:  James W T Toh; Kevin Phan; Kerry Hitos; Nimalan Pathma-Nathan; Toufic El-Khoury; Arthur J Richardson; Gary Morgan; Alexander Engel; Grahame Ctercteko
Journal:  JAMA Netw Open       Date:  2018-10-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.